US equities
|
NVDA
$150.96
▼-2.89%
MU
$705.27
▼-1.00%
AMD
$530.14
▲+5.31%
SPCX
$143.50
▲+1.27%
AAPL
$352.45
▲+0.15%
MSFT
$508.29
▲+0.40%
AMZN
$267.74
▲+3.82%
TSLA
$383.72
▲+0.95%
NVDA
$150.96
▼-2.89%
MU
$705.27
▼-1.00%
AMD
$530.14
▲+5.31%
SPCX
$143.50
▲+1.27%
AAPL
$352.45
▲+0.15%
MSFT
$508.29
▲+0.40%
AMZN
$267.74
▲+3.82%
TSLA
$383.72
▲+0.95%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about FDA Priority Review
Recent news which mentions FDA Priority Review
Agios' Rare Anemia Drug Application Under FDA Priority Review
August 18, 2021
Tickers
AGIO
Tags
Health Care
AGIO
General
From
Benzinga
Liminal BioSciences Stock Is Trading Higher On Sale Of Priority Review Voucher For $105M
August 09, 2021
Tickers
LMNL
Tags
Health Care
Market News
FDA Priority Review
From
Benzinga
Daré Bioscience Stock Is Trading Higher As Bacterial Vaginosis Candidate Secures FDA Priority Review
August 09, 2021
Tickers
DARE
Tags
Benzinga
Penny Stocks
DARE
From
Benzinga
Roche's Tecentriq As Adjuvant Treatment Under Priority Review With FDA For Early Lung Cancer
August 03, 2021
Tickers
RHHBF
RHHBY
RHHVF
Tags
News
RHHBY
Biotech
From
Benzinga